Walgreens Boots Alliance (WBA) Expected to Beat Earnings Estimates: Should You Buy? — Positive

WBA   Zacks Investment Research — March 20, 2025

Walgreens (WBA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Walgreens Boots Alliance (WBA) Expected to Beat Earnings Estimates: Should You Buy?

Lululemon (LULU) Reports Next Week: Wall Street Expects Earnings Growth — Positive

LULU   Zacks Investment Research — March 20, 2025

Lululemon (LULU) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Lululemon (LULU) Reports Next Week: Wall Street Expects Earnings Growth

PLDT: A New Hope After Its Deep Plunge — Positive

PHI   Seeking Alpha — March 20, 2025

PLDT, Inc. continues to show solid revenue growth and robust Q4 2024 performance, aligning with my DCF projections. Maya's rapid subscriber growth and profitability, coupled with favorable economic conditions, position it as a key growth driver for PLDT in FY25. PLDT's extensive data center investments and strong liquidity ensure it remains competitive and capable of sustaining expansion and capital requirements.

image for news PLDT: A New Hope After Its Deep Plunge

MAHWAH, N.J., March 20, 2025 (GLOBE NEWSWIRE) -- Radware ® (NASDAQ: RDWR), a global leader in application security and delivery solutions for multi-cloud environments, has been named a Strong Performer in The Forrester Wave: Web Application Firewall Solutions, Q1 2025. Radware was among the 10 top web application firewall (WAF) vendors included in the market overview.

image for news Radware Named as a Strong Performer in Analyst Report for Web Application Firewall Solutions

NEW YORK, NY / ACCESS Newswire / March 20, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neumora-therapeutics-inc-lawsuit-submission-form?prid=137467&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in Neumora Therapeutics, Inc. Lawsuit - NMRA

Marsh McLennan to Host First Quarter Earnings Investor Call on April 17 — Neutral

MMC   Business Wire — March 20, 2025

NEW YORK--(BUSINESS WIRE)--Marsh McLennan (NYSE: MMC), a global leader in risk, strategy and people, will announce first quarter financial results via news release on Thursday, April 17, 2025, before the market opens. The news release will be available on marshmclennan.com. Following the news release, President and CEO John Doyle and CFO Mark McGivney will lead a teleconference with investors at 8:30 a.m. EDT. The discussion will include a question-and-answer session. The live audio webcast wil.

image for news Marsh McLennan to Host First Quarter Earnings Investor Call on April 17

WAYNE, Pa., March 20, 2025 (GLOBE NEWSWIRE) -- Elemica, a global leader of digital supply chain management solutions and the premier multi-enterprise collaboration network for process manufacturing industries, proudly announces its achievement of FedEx's Compatible Platinum Tier—a top recognition within the FedEx Compatible program. This prestigious designation places ProcessWeaver by Elemica among the top FedEx-integrated solutions, recognizing its advanced capabilities in shipping automation, real-time tracking, and seamless multi-carrier multi-modal connectivity for customers worldwide.

image for news Elemica™ Awarded with FedEx Compatible Platinum Tier for the 3rd Consecutive Year

NEW YORK, NY / ACCESS Newswire / March 20, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form?prid=137469&wire=1 or contact Joseph E. Levi, Esq.

image for news Investors in Novo Nordisk A/S Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - NVO

NEW YORK, NY / ACCESS Newswire / March 20, 2025 / If you suffered a loss on your e.l.f. Beauty, Inc. (NYSE:ELF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/e-l-f-beauty-lawsuit-submission-form?prid=137468&wire=1 or contact Joseph E.

image for news Class Action Filed Against e.l.f. Beauty, Inc. (ELF) - May 5, 2025 Deadline to Join - Contact Levi & Korsinsky

SAN DIEGO, March 20, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers of Archer Daniels Midland Company (NYSE: ADM) concerning their obligations to the company's shareholders.

image for news ADM INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Archer Daniels Midland for Breach of Fiduciary Duties

Microsoft is adding another 475 megawatts to its already considerable renewable powered portfolio to feed the growing energy appetite of its data centers. The company recently signed a deal with energy provider AES for three solar projects across the Midwest, one each in Illinois, Michigan, and Missouri.

image for news Solar notches another win as Microsoft adds 475 MW to power its AI data centers

Why Accenture Stock Tumbled on Thursday — Negative

ACN   The Motley Fool — March 20, 2025

Accenture (ACN -6.83%) stock fell 8% through 10 a.m. ET Thursday despite exceeding expectations in its earnings report for the fiscal second quarter of 2025.

image for news Why Accenture Stock Tumbled on Thursday

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Polestar To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / If you purchased or acquired securities in Polestar between November 14, 2022 and January 16, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Polestar Automotive …

image for news INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Polestar Automotive

Atour Lifestyle to Post Q4 Earnings: What's in Store for the Stock? — Positive

ATAT   Zacks Investment Research — March 20, 2025

ATAT's fourth-quarter 2024 top line is likely to have been driven by strong domestic travel demand, growth in its membership base, strategic expansion and brand enhancements.

image for news Atour Lifestyle to Post Q4 Earnings: What's in Store for the Stock?

Star Equity (STRR) Q4 Earnings and Revenues Top Estimates — Positive

STRR   Zacks Investment Research — March 20, 2025

Star Equity (STRR) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of a loss of $0.17 per share. This compares to loss of $0.10 per share a year ago.

image for news Star Equity (STRR) Q4 Earnings and Revenues Top Estimates

ALX Oncology Holdings (ALXO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

image for news ALX Oncology Holdings (ALXO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

The average of price targets set by Wall Street analysts indicates a potential upside of 26.6% in Canadian Natural Resources (CNQ). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

image for news Wall Street Analysts Think Canadian Natural Resources (CNQ) Could Surge 26.6%: Read This Before Placing a Bet

The consensus price target hints at a 28% upside potential for Pediatrix Medical Group (MD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

image for news Wall Street Analysts Think Pediatrix Medical Group (MD) Could Surge 27.97%: Read This Before Placing a Bet

Here's Why Matson (MATX) Is a Great 'Buy the Bottom' Stock Now — Positive

MATX   Zacks Investment Research — March 20, 2025

After losing some value lately, a hammer chart pattern has been formed for Matson (MATX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

image for news Here's Why Matson (MATX) Is a Great 'Buy the Bottom' Stock Now

Can Gray Media (GTN) Climb 31.84% to Reach the Level Wall Street Analysts Expect? — Positive

GTN   Zacks Investment Research — March 20, 2025

The average of price targets set by Wall Street analysts indicates a potential upside of 31.8% in Gray Media (GTN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

image for news Can Gray Media (GTN) Climb 31.84% to Reach the Level Wall Street Analysts Expect?